Multiplex Detection Immunoassays Market Size to Touch US$ 3.5 billion by 2030

Multiplex Detection Immunoassays Market (By Assay Type: Planar Assay, Bead-based Assay; By Technique: Nucleic Acid-based Techniques, Protein-based Techniques, Biosensor-based Techniques; By Application: Disease Testing, Food Contamination Testing, R&D, Veterinary Disease Testing; By End User) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2021-2030

The global multiplex detection immunoassays market size is expected to be worth around US$ 3.5 billion by 2030, according to a new report by Vision Research Reports. size was valued at US$ 1.6 billion in 2020 and is anticipated to grow at a CAGR of 7.3% during forecast period 2021 to 2030.

The high prevalence and increase in incidence rate of chronic and infectious diseases are projected to drive the global multiplex detection immunoassays market in the near future.

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38200

Growth Factor

Multiplex immunoassays provide sufficient analytical performance to evaluate serum biomarkers that complement each other in the detection of a larger number of patient samples. The use of differentially detectable beads of different regions enables simultaneous identification and quantification of multiple analytes in the same sample allowing the individual immunoassays to be multiplexed.

The market growth is primarily driven by a host of factors, including increasing need for swift and early detection of antibiotic residues for food and environmental protection, significant rise in the prevalence of infectious and chronic diseases, and increase in emphasis on research and development. The outbreak of the COVID-19 pandemic will play a key role in accelerating research and development activities, as researchers and scientists continue to leverage multiplex detection immunoassays for the detection of human coronaviruses worldwide.

Key Players

Leading players operating in the global multiplex detection immunoassays market include Hoffmann-La Roche Ltd., QIAGEN, Merck KGaA, Microsynth AG, Bio-Rad Laboratories, Thermo Fisher Scientific, Luminex Corporation, and Becton, Dickinson and Company.

Market Segmentation

By Assay Type

• Planar Assay
• Blends Protein Arrays (Multiplexed ELISA)
• Antibody Arrays
• Bead-based Assay
• Magnetic Bead-based
• Non-magnetic Bead-based

By Technique

• Nucleic Acid-based Techniques
• Protein-based Techniques
• Biosensor-based Techniques

By Application

• Disease Testing
• Infectious Disease Testing
• Autoimmune Disease Testing
• Other Diseases Testing
• Food Contamination Testing
• Research & Development
• Veterinary Disease Testing

By End User

• Pharmaceutical & Biopharmaceutical Companies
• Clinical Research Organizations
• Food & Beverages Industry
• Academic & Research Institutes
• Diagnostic Centers
• Others

By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Buy This Report, click here@  https://www.visionresearchreports.com/report/cart/38200

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Multiplex Detection Immunoassays Market, By Assay Type

7.1.  Multiplex Detection Immunoassays Market, by Assay Type, 2021-2030

7.1.1.    Planar Assay

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Blends Protein Arrays (Multiplexed ELISA)

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Antibody Arrays

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Bead-based Assay

7.1.4.1.        Market Revenue and Forecast (2017-2030)

7.1.5.    Magnetic Bead-based

7.1.5.1.        Market Revenue and Forecast (2017-2030)

7.1.6.    Non-magnetic Bead-based

7.1.6.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Multiplex Detection Immunoassays Market, By Technique

8.1.  Multiplex Detection Immunoassays Market, by Technique, 2021-2030

8.1.1.    Nucleic Acid-based Techniques

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Protein-based Techniques

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Biosensor-based Techniques

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Multiplex Detection Immunoassays Market, By Application

9.1.  Multiplex Detection Immunoassays Market, by Application, 2021-2030

9.1.1.    Disease Testing

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Infectious Disease Testing

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Autoimmune Disease Testing

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Other Diseases Testing

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Food Contamination Testing

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Research & Development

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Veterinary Disease Testing

9.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Multiplex Detection Immunoassays Market, By End User

10.1.        Multiplex Detection Immunoassays Market, by End User, 2021-2030

10.1.1.  Pharmaceutical & Biopharmaceutical Companies

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Clinical Research Organizations

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Food & Beverages Industry

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Academic & Research Institutes

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Diagnostic Centers

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Others

10.1.6.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global Multiplex Detection Immunoassays Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.1.3.  Market Revenue and Forecast, by Application (2017-2030)

11.1.4.  Market Revenue and Forecast, by End User (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.2.3.  Market Revenue and Forecast, by Application (2017-2030)

11.2.4.  Market Revenue and Forecast, by End User (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by End User (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.3.3.  Market Revenue and Forecast, by Application (2017-2030)

11.3.4.  Market Revenue and Forecast, by End User (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by End User (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.4.3.  Market Revenue and Forecast, by Application (2017-2030)

11.4.4.  Market Revenue and Forecast, by End User (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by End User (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Application (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by End User (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.2.  Market Revenue and Forecast, by Technique (2017-2030)

11.5.3.  Market Revenue and Forecast, by Application (2017-2030)

11.5.4.  Market Revenue and Forecast, by End User (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by End User (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Technique (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Application (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 12.  Company Profiles

12.1.              Hoffmann-La Roche Ltd.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              QIAGEN

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Merck KGaA

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Microsynth AG

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Bio-Rad Laboratories

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Thermo Fisher

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Luminex Corporation

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Becton

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Dickinson and Company

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms

Buy This Report, click here@  https://www.visionresearchreports.com/report/cart/38200           

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com